Log In
Print this Print this

AR-201 (formerly KBRV201)

  Manage Alerts
Collapse Summary General Information
Company Aridis Pharmaceuticals Inc.
DescriptionHuman mAb against respiratory virus generated using the MabIgX platform technology
Molecular Target RSV F protein
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory infection
Indication DetailsPrevent respiratory virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today